HonorHealth Research Institute treats 1st patient in 50-site melanoma clinical trial
HonorHealth Research Institute recently treated the first patient in a 50-site international clinical trial that will test a new type of therapy aimed at difficult-to-treat melanoma, an aggressive type of…